EMA TO Open UP Article 57 Pharmacovigilance Database to Simplify Regulatory Changes
This article was originally published in SRA
The European Medicines Agency will soon open up its database to national competent authorities to give them access to information on the qualified person for pharmacovigilance (QPPVs) and the location of pharmacovigilance system master file (PSMF) for each drug authorized in the EU. Once this happens there will be no need for drug companies to submit variation applications with regard to changes on these fronts1.
You may also be interested in...
The European Medicines Agency is developing a strategy to ensure that women have sufficient information to make informed choices about taking medicines during pregnancy and breastfeeding.
A first-of-its-kind collaborative study has found that real-world and natural history data are comparable to placebo data from clinical trials in Duchenne muscular dystrophy.
An EU group has listed several ambitious projects to help EU regulators realize their cherished vision of using big data capabilities to support innovation and public health. But these proposals may take a backseat as COVID-19-related challenges continue.